Caseware UK (AP4) 2024.0.164 2024.0.164 2024-11-302024-11-30false2023-12-015No description of principal activity5falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08786525 2023-12-01 2024-11-30 08786525 2022-12-01 2023-11-30 08786525 2024-11-30 08786525 2023-11-30 08786525 c:Director5 2023-12-01 2024-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar 2024-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar 2023-11-30 08786525 d:CurrentFinancialInstruments 2024-11-30 08786525 d:CurrentFinancialInstruments 2023-11-30 08786525 d:CurrentFinancialInstruments d:WithinOneYear 2024-11-30 08786525 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 08786525 d:ShareCapital 2024-11-30 08786525 d:ShareCapital 2023-11-30 08786525 d:RetainedEarningsAccumulatedLosses 2024-11-30 08786525 d:RetainedEarningsAccumulatedLosses 2023-11-30 08786525 c:FRS102 2023-12-01 2024-11-30 08786525 c:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 08786525 c:FullAccounts 2023-12-01 2024-11-30 08786525 c:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 08786525 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2023-12-01 2024-11-30 08786525 e:PoundSterling 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Registered number: 08786525









COV-A-BLIND LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

 
COV-A-BLIND LTD
REGISTERED NUMBER: 08786525

BALANCE SHEET
AS AT 30 NOVEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
2,610
2,954

Current assets
  

Stocks
  
92,221
81,726

Debtors: amounts falling due within one year
 5 
14,693
3,702

Cash at bank and in hand
  
9,517
8,867

  
116,431
94,295

Creditors: amounts falling due within one year
 6 
(162,969)
(141,641)

Net current liabilities
  
 
 
(46,538)
 
 
(47,346)

  

Net liabilities
  
(43,928)
(44,392)


Capital and reserves
  

Called up share capital 
  
3
3

Profit and loss account
  
(43,931)
(44,395)

  
(43,928)
(44,392)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
COV-A-BLIND LTD
REGISTERED NUMBER: 08786525
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2024

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 August 2025.




O Gualtieri
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1.


General information

Cov-A-Blind Ltd ("the Company") is a private company limited by shares, incorporated in England and Wales. Its registered office is 16 Lockfield Avenue, Enfield, England, EN3 7PX. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The Company continues to have the support of entities under common control and the accounts have therefore been prepared on the going concern basis.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of income and retained earnings except when deferred in other comprehensive income as qualifying cash flow hedges.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Page 3

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to the Statement of income and retained earnings over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis.

 
2.8

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.10

Creditors

Short term creditors are measured at the transaction price.


3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2023 - 5).

Page 4

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

4.


Intangible assets




Patents

£



Cost


At 1 December 2023
3,441



At 30 November 2024

3,441



Amortisation


At 1 December 2023
487


Charge for the year on owned assets
344



At 30 November 2024

831



Net book value



At 30 November 2024
2,610



At 30 November 2023
2,954




5.


Debtors

2024
2023
£
£


Trade debtors
220
143

Other debtors
14,473
1,103

Prepayments and accrued income
-
2,456

14,693
3,702


Page 5

 
COV-A-BLIND LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
3,756
67,072

Other taxation and social security
274
-

Other creditors
157,239
72,869

Accruals and deferred income
1,700
1,700

162,969
141,641


 
Page 6